Strata Critical Medical (NASDAQ:SRTA) CAO Sells $239,798.25 in Stock

Posted by George Bondi on May 26th, 2026

Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CAO Amir Cohen sold 40,575 shares of the stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $5.91, for a total value of $239,798.25. Following the transaction, the chief accounting officer owned 151,263 shares in the company, valued at $893,964.33. The trade was a 21.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Amir Cohen also recently made the following trade(s):

On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.79, for a total value of $59,637.00.

Strata Critical Medical Price Performance

SRTA stock traded up $0.01 during trading hours on Tuesday, hitting $6.14. 981,609 shares of the stock were exchanged, compared to its average volume of 869,593. The firm has a market cap of $531.29 million, a price-to-earnings ratio of -76.75 and a beta of 2.15. The firm has a 50-day moving average price of $4.82. Strata Critical Medical has a 12 month low of $3.40 and a 12 month high of $6.27.

Strata Critical Medical (NASDAQ:SRTA – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.07. The firm had revenue of $67.38 million for the quarter. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%. Equities research analysts anticipate that Strata Critical Medical will post -0.14 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on SRTA. Craig Hallum began coverage on Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective on the stock. B. Riley Financial began coverage on Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective on the stock. Zacks Research upgraded Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. Finally, Weiss Ratings upgraded Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $8.00.

Read Our Latest Analysis on Strata Critical Medical

Institutional Trading of Strata Critical Medical

Several large investors have recently bought and sold shares of the business. Bank of America Corp DE boosted its stake in Strata Critical Medical by 16.2% in the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after buying an additional 25,379 shares in the last quarter. Quantinno Capital Management LP boosted its stake in Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after buying an additional 71,155 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after buying an additional 172,154 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in Strata Critical Medical in the first quarter valued at about $537,000. Finally, Granite Investment Partners LLC boosted its stake in Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after buying an additional 7,911 shares in the last quarter. 47.36% of the stock is owned by institutional investors and hedge funds.

About Strata Critical Medical

(Get Free Report)

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.